Atlas Trials

Safety and Tolerability Evaluation of MaaT033

Clinical trial NCT04150393 · COMPLETED

Trial details

NCT number
NCT04150393
Sponsor
MaaT Pharma
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Hematologic DiseasesChemotherapy Effect
Start date
2020-10-20
Primary completion
2021-12-13
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.